Yatharth Hospital & Trauma Care Services Limited announced its participation in two key investor engagement events in Mumbai during late September 2026. The hospital chain will feature at the Nuvama Emerging India CEO Forum on Monday, September 28, followed by sell-side meetings on Tuesday, September 29.

The company filed an intimation with stock exchanges under Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These disclosures ensure transparency regarding management interactions with the investment community.

Event Schedule

The management team will engage with analysts and investors through both conference presentations and direct one-to-one sessions. The specific details of the scheduled events are outlined below:

Compliance and Disclosure

The company stated that no unpublished price sensitive information (UPSI) would be shared during these interactions. This adherence to regulatory norms ensures a level playing field for all market participants. The schedule remains subject to change based on exigencies from either the investors or the company side.

Investors can access further details via the company's official website under the corporate announcements section. The filing was signed by Ritesh Mishra, Company Secretary & Compliance Officer.

Yatharth Hospital has entered into a definitive agreement with global private equity firm Advent International to secure a ₹3,150.00 crore primary investment. The transaction values the hospital chain significantly as Advent acquires a 24.9% minority stake, subject to customary closing conditions.

The board meeting held on September 17, 2026 approved this preferential issue of equity shares and warrants. This infusion marks one of the largest primary capital injections by a private equity firm in India's hospital sector. The promoter, the Tyagi Family, will remain the largest shareholder.

Transaction Structure

The investment comprises two components issued on a private placement basis:

• Equity Shares: Up to 1,30,26,516 fully paid-up equity shares at ₹985.17 per share, aggregating ₹1,283.33 crore.
• Warrants: Up to 1,89,47,664 warrants at ₹985.17 each. Twenty-five percent (₹246.29) is payable upfront, with the balance 75% (₹738.88) due upon exercise.

Rasmalai Limited, the Cyprus-based entity through which Advent invests, will hold the stake on a fully diluted basis. Upon completion, the investor will be classified as a public shareholder.

Strategic Context

Founded in 2008, Yatharth Hospital operates nine multi-speciality hospitals with approximately 2,800 beds and an announced capacity of ~3,250 beds across North India. The company has expanded through organic growth and strategic acquisitions in the National Capital Region, Madhya Pradesh, and Haryana.

Mr. Yatharth Tyagi, Whole-time Director, stated that the investment validates the platform's strength and long-term vision. He noted that Advent brings deep healthcare expertise and global insights to accelerate the next phase of growth.

Pankaj Patwari, Managing Director at Advent, highlighted the structural growth potential in India's healthcare sector. He emphasized the partnership with the founder-led business to support scalable operations and clinical excellence.

Shareholder Approval Process

To formalize the transaction, the company has scheduled an Extra-Ordinary General Meeting (EGM) for October 15, 2026. The meeting will be conducted via video conferencing. Key resolutions include increasing the authorized share capital from ₹115 crore to ₹150 crore to accommodate the new shares and warrants. Shareholders will also vote on adopting amended articles of association to incorporate special rights granted to the investor and promoter group.

What the Numbers Show

The warrant structure defers significant capital inflow. While the upfront cash consideration includes the full equity value plus only 25% of the warrant value, the remaining 75% of the warrant consideration is contingent on future exercise. This aligns immediate liquidity with long-term equity conversion potential for the hospital chain.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0JO301016/4b15047b-63b0-4d63-a43c-70e329a43a2f.pdf